VALNEVA SE SP.ADS/2
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile t… Read more
Market Cap & Net Worth: VALNEVA SE SP.ADS/2 (AYJ0)
VALNEVA SE SP.ADS/2 (F:AYJ0) has a market capitalization of $798.13 Million (€777.55 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #8958 globally and #963 in its home market, demonstrating a 2.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VALNEVA SE SP.ADS/2's stock price €9.05 by its total outstanding shares 85916977 (85.92 Million).
VALNEVA SE SP.ADS/2 Market Cap History: 2021 to 2026
VALNEVA SE SP.ADS/2's market capitalization history from 2021 to 2026. Data shows change from $4.36 Billion to $798.13 Million (-18.41% CAGR).
VALNEVA SE SP.ADS/2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VALNEVA SE SP.ADS/2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AYJ0 by Market Capitalization
Companies near VALNEVA SE SP.ADS/2 in the global market cap rankings as of March 19, 2026.
Key companies related to VALNEVA SE SP.ADS/2 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
VALNEVA SE SP.ADS/2 Historical Marketcap From 2021 to 2026
Between 2021 and today, VALNEVA SE SP.ADS/2's market cap moved from $4.36 Billion to $ 798.13 Million, with a yearly change of -18.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €798.13 Million | +23.97% |
| 2025 | €643.80 Million | +65.91% |
| 2024 | €388.04 Million | -51.65% |
| 2023 | €802.54 Million | -26.32% |
| 2022 | €1.09 Billion | -75.00% |
| 2021 | €4.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of VALNEVA SE SP.ADS/2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $798.13 Million USD |
| MoneyControl | $798.13 Million USD |
| MarketWatch | $798.13 Million USD |
| marketcap.company | $798.13 Million USD |
| Reuters | $798.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.